Brief: Tianda Pharmaceuticals Says Unit To Buy 45% Stake In Yunnan Meng Sheng Pharmaceutical
01/08/2023 13:22
Aug 1 (Reuters) - Tianda Pharmaceuticals Ltd 0455.HK :
* YUNYU BIO-PHARMACEUTICAL CO TO ACQUIRE 45% OF THE ENTIRE
EQUITY
INTEREST IN YUNNAN MENG SHENG PHARMACEUTICAL
* ACQUISITION OF NON-CONTROLLING INTEREST IN A SUBSIDIARY
* DEAL FOR RMB23.5 MILLION
Further company coverage: 0455.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianda Pharmaceuticals
See all newsBrief: Tianda Pharmaceuticals Says Loss Attributable Expected To Increase To Hk$61 Million For FY
Brief: Tianda Pharmaceuticals Clarifies On Fraudulent Fund Raising Scams
Brief: Tianda Pharmaceuticals Sees Loss Attributable For Interim Period Increase To Not Less Than HK$27 Mln
Brief: Tianda Pharmaceuticals Says Unit Granted Drug Registration Approval Of Ibuprofen Suspension By NMPA
Brief: Tianda Pharmaceuticals Says Drug Registration Approval Of "Nicorandil For Injection" By NMPA